Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 2750695, 18 pages
https://doi.org/10.1155/2018/2750695
Research Article

Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling

1Department of Cardiovascular Surgery, General Hospital of Shenyang Military Region, 83 Wenhua Road, Shenyang, Liaoning 110016, China
2Department of Pharmacy, General Hospital of Shenyang Military Region, 83 Wenhua Road, Shenyang, Liaoning 110016, China
3Department of Neurosurgery, General Hospital of Shenyang Military Region, 83 Wenhua Road, Shenyang, Liaoning 110016, China
4Faculty of Life Science, Northwest University, 229 Taibai North Road, Xi’an, Shaanxi 710069, China
5Department of Biomedical Engineering, The Fourth Military Medical University, 169 Changle West Road, Xi’an, Shaanxi 710032, China

Correspondence should be addressed to Yang Yang; moc.361@yy412002gnay and Huishan Wang; moc.621@wnahsiuh

Received 9 September 2017; Revised 21 November 2017; Accepted 6 December 2017; Published 13 February 2018

Academic Editor: Silvana Hrelia

Copyright © 2018 Liming Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Jia, “Diabetes research in China: making progress,” The Lancet Diabetes & Endocrinology, vol. 5, no. 1, pp. 9-10, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Huynh, B. C. Bernardo, J. R. McMullen, and R. H. Ritchie, “Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways,” Pharmacology & Therapeutics, vol. 142, no. 3, pp. 375–415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Chen, D. J. Magliano, and P. Z. Zimmet, “The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives,” Nature Reviews Endocrinology, vol. 8, no. 4, pp. 228–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Schnell, F. Cappuccio, S. Genovese, E. Standl, P. Valensi, and A. Ceriello, “Type 1 diabetes and cardiovascular disease,” Cardiovascular Diabetology, vol. 12, no. 1, p. 156, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Yu, H. Liang, X. Dong et al., “Reduced silent information regulator 1 signaling exacerbates myocardial ischemia-reperfusion injury in type 2 diabetic rats and the protective effect of melatonin,” Journal of Pineal Research, vol. 59, no. 3, pp. 376–390, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Zhai, B. Li, W. Duan et al., “Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis,” Journal of Pineal Research, vol. 63, no. 2, article e12419, 2017. View at Publisher · View at Google Scholar
  7. T. Baranyai, C. T. Nagy, G. Koncsos et al., “Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning,” Cardiovascular Diabetology, vol. 14, no. 1, p. 151, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Zhou, Y. Bao, H. Li et al., “Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia/reperfusion injury and diabetes-induced cardiac dysfunction,” Clinical Science, vol. 129, no. 7, pp. 547–559, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Luxan, G. D'Amato, D. MacGrogan, and J. L. de la Pompa, “Endocardial Notch signaling in cardiac development and disease,” Circulation Research, vol. 118, no. 1, pp. e1–e18, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ferrari and P. Rizzo, “The Notch pathway: a novel target for myocardial remodelling therapy?” European Heart Journal, vol. 35, no. 32, pp. 2140–2145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Yu, F. Li, G. Zhao et al., “Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling,” Apoptosis, vol. 20, no. 6, pp. 796–810, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Yu, H. Liang, Z. Lu et al., “Membrane receptor-dependent Notch1/Hes1 activation by melatonin protects against myocardial ischemia-reperfusion injury: in vivo and in vitro studies,” Journal of Pineal Research, vol. 59, no. 4, pp. 420–433, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Pei, Q. Yu, Q. Xue et al., “Notch1 cardioprotection in myocardial ischemia/reperfusion involves reduction of oxidative/nitrative stress,” Basic Research in Cardiology, vol. 108, no. 5, p. 373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. H. Du, C. Peng, and H. Zhang, “Polydatin: a review of pharmacology and pharmacokinetics,” Pharmaceutical Biology, vol. 51, no. 11, pp. 1347–1354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. L. T. Liu, G. Guo, M. Wu, and W. G. Zhang, “The progress of the research on cardio-vascular effects and acting mechanism of polydatin,” Chinese Journal of Integrative Medicine, vol. 18, no. 9, pp. 714–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Liu, P. Chen, J. Deng, J. Lv, and J. Liu, “Resveratrol and polydatin as modulators of Ca2+ mobilization in the cardiovascular system,” Annals of the New York Academy of Sciences, vol. 1403, no. 1, pp. 82–91, 2017. View at Publisher · View at Google Scholar
  17. J. Deng, W. Liu, Y. Wang, M. Dong, M. Zheng, and J. Liu, “Polydatin modulates Ca2+ handling, excitation-contraction coupling and β-adrenergic signaling in rat ventricular myocytes,” Journal of Molecular and Cellular Cardiology, vol. 53, no. 5, pp. 646–656, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ling, G. Chen, Y. Deng et al., “Polydatin post-treatment alleviates myocardial ischaemia/reperfusion injury by promoting autophagic flux,” Clinical Science, vol. 130, no. 18, pp. 1641–1653, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Ming, L. Songyan, C. Yawen et al., “trans-Polydatin protects the mouse heart against ischemia/reperfusion injury via inhibition of the renin-angiotensin system (RAS) and Rho kinase (ROCK) activity,” Food & Function, vol. 8, no. 6, pp. 2309–2321, 2017. View at Publisher · View at Google Scholar
  20. B. Huang, L. Xue, Y. Wu, and Q. S. Jiang, “Effect and mechanism of polydatin on diabetic myocardial hypertrophy in mice,” Zhongguo Zhong Yao Za Zhi, vol. 40, no. 21, pp. 4256–4261, 2015. View at Google Scholar
  21. L. Yu, B. Gong, W. Duan et al., “Melatonin ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1α-SIRT3 signaling,” Scientific Report, vol. 7, article 41337, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Yu, S. Li, X. Tang et al., “Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation,” Apoptosis, vol. 22, no. 7, pp. 942–954, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Yu, C. Fan, Z. Li et al., “Melatonin rescues cardiac thioredoxin system during ischemia-reperfusion injury in acute hyperglycemic state by restoring Notch1/Hes1/Akt signaling in a membrane receptor-dependent manner,” Journal of Pineal Research, vol. 62, no. 1, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Zhang, L. M. Yu, H. Zhao et al., “2,3,5,4-Tetrahydroxystilbene-2-O-β-D-glucoside protects murine hearts against ischemia/reperfusion injury by activating Notch1/Hes1 signaling and attenuating endoplasmic reticulum stress,” Acta Pharmacologica Sinica, vol. 38, no. 3, pp. 317–330, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Pei, X. Song, C. Peng et al., “TNF-α inhibitor protects against myocardial ischemia/reperfusion injury via Notch1-mediated suppression of oxidative/nitrative stress,” Free Radical Biology & Medicine, vol. 82, pp. 114–121, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Boccalini, C. Sassoli, L. Formigli, D. Bani, and S. Nistri, “Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway,” The FASEB Journal, vol. 29, no. 1, pp. 239–249, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Miao, S. Wang, S. Miao, J. Wang, Y. Xie, and Q. Yang, “Cardioprotective effect of polydatin against ischemia/reperfusion injury: roles of protein kinase C and mito KATP activation,” Phytomedicine, vol. 19, no. 1, pp. 8–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Otani, “The role of nitric oxide in myocardial repair and remodeling,” Antioxidants & Redox Signaling, vol. 11, no. 8, pp. 1913–1928, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. Q. Yu, F. Gao, and X. L. Ma, “Insulin says NO to cardiovascular disease,” Cardiovascular Research, vol. 89, no. 3, pp. 516–524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Huang, Y. Cui, L. Ji et al., “Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult,” Pharmaceutical Biology, vol. 51, no. 4, pp. 463–473, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. T. J. Orchard and T. Costacou, “When are type 1 diabetic patients at risk for cardiovascular disease?” Current Diabetes Reports, vol. 10, no. 1, pp. 48–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. J. Domanski and M. E. Farkouh, “Type 1 diabetes, coronary disease complexity, and optimal revascularization strategy,” Journal of the American College of Cardiology, vol. 70, no. 12, pp. 1452–1454, 2017. View at Publisher · View at Google Scholar
  33. Z. Shi, F. Fu, L. Yu et al., “Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 308, no. 4, pp. H281–H290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. D. M. Ansley and B. Wang, “Oxidative stress and myocardial injury in the diabetic heart,” The Journal of Pathology, vol. 229, no. 2, pp. 232–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Isfort, S. C. Stevens, S. Schaffer, C. J. Jong, and L. E. Wold, “Metabolic dysfunction in diabetic cardiomyopathy,” Heart Failure Reviews, vol. 19, no. 1, pp. 35–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Rodriguez, M. C. Weiss, H. Weintraub, I. J. Goldberg, and A. Schwartzbard, “Cardiovascular disease leads to a new algorithm for diabetes treatment,” Journal of Clinical Lipidology, vol. 11, no. 5, pp. 1126–1133, 2017. View at Publisher · View at Google Scholar
  37. Y. Wang, E. Gao, L. Tao et al., “AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin,” Circulation, vol. 119, no. 6, pp. 835–844, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Li, J. Li, J. Liu et al., “Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart,” Free Radical Biology & Medicine, vol. 46, no. 3, pp. 397–405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Karbach, P. Wenzel, A. Waisman, T. Munzel, and A. Daiber, “eNOS uncoupling in cardiovascular diseases—the role of oxidative stress and inflammation,” Current Pharmaceutical Design, vol. 20, no. 22, pp. 3579–3594, 2014. View at Publisher · View at Google Scholar
  40. J. Zaman, S. Jeddi, M. S. Daneshpour, M. Zarkesh, Z. Daneshian, and A. Ghasemi, “Ischemic postconditioning provides cardioprotective and antiapoptotic effects against ischemia-reperfusion injury through iNOS inhibition in hyperthyroid rats,” Gene, vol. 570, no. 2, pp. 185–190, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Zhu, Q. Yao, W. Wang, H. Yao, and J. Chao, “iNOS induces vascular endothelial cell migration and apoptosis via autophagy in ischemia/reperfusion injury,” Cellular Physiology and Biochemistry, vol. 38, no. 4, pp. 1575–1588, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Valle Raleigh, A. G. Mauro, T. Devarakonda et al., “Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism,” Cardiovascular Research, vol. 113, no. 6, pp. 609–619, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Gonzalez, E. Herradon, R. Abalo et al., “Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia-reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 4, pp. 331–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Jeddi, S. Khalifi, M. Ghanbari, F. Bageripour, and A. Ghasemi, “Effects of nitrate intake on myocardial ischemia-reperfusion injury in diabetic rats,” Arquivos Brasileiros de Cardiologia, vol. 107, no. 4, pp. 339–347, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Ye, Y. Lin, S. Manickavasagam, J. R. Perez-Polo, B. C. Tieu, and Y. Birnbaum, “Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 295, no. 6, pp. H2436–H2446, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Qiao and H. Chen, “Polydatin attenuates H2O2-induced oxidative stress via PKC pathway,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 5139458, 10 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Ma, X. Gong, Y. Mo, and S. Wu, “Polydatin inhibits the oxidative stress-induced proliferation of vascular smooth muscle cells by activating the eNOS/SIRT1 pathway,” International Journal of Molecular Medicine, vol. 37, no. 6, pp. 1652–1660, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Collesi, L. Zentilin, G. Sinagra, and M. Giacca, “Notch1 signaling stimulates proliferation of immature cardiomyocytes,” The Journal of Cell Biology, vol. 183, no. 1, pp. 117–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. N. A. Gude, G. Emmanuel, W. Wu et al., “Activation of Notch-mediated protective signaling in the myocardium,” Circulation Research, vol. 102, no. 9, pp. 1025–1035, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Felician, C. Collesi, M. Lusic et al., “Epigenetic modification at Notch responsive promoters blunts efficacy of inducing notch pathway reactivation after myocardial infarction,” Circulation Research, vol. 115, no. 7, pp. 636–649, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Dror, V. Nguyen, P. Walia, T. B. Kalynyak, J. A. Hill, and J. D. Johnson, “Notch signalling suppresses apoptosis in adult human and mouse pancreatic islet cells,” Diabetologia, vol. 50, no. 12, pp. 2504–2515, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Liu, X. Ma, Q. Ai et al., “NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma,” Urologic Oncology, vol. 31, no. 6, pp. 938–948, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Palomero, M. Dominguez, and A. A. Ferrando, “The role of the PTEN/AKT pathway in NOTCH1-induced leukemia,” Cell Cycle, vol. 7, no. 8, pp. 965–970, 2008. View at Publisher · View at Google Scholar
  54. T. Palomero, M. L. Sulis, M. Cortina et al., “Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia,” Nature Medicine, vol. 13, no. 10, pp. 1203–1210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Maehama, G. S. Taylor, and J. E. Dixon, “PTEN and myotubularin: novel phosphoinositide phosphatases,” Annual Review of Biochemistry, vol. 70, no. 1, pp. 247–279, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Yu, B. Li, M. Zhang et al., “Melatonin reduces PERK-eIF2α-ATF4-mediated endoplasmic reticulum stress during myocardial ischemia-reperfusion injury: role of RISK and SAFE pathways interaction,” Apoptosis, vol. 21, no. 7, pp. 809–824, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Ji, F. Fu, L. Zhang et al., “Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress,” American Journal of Physiology. Endocrinology and Metabolism, vol. 298, no. 4, pp. E871–E880, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Lei, H. Li, J. Xu et al., “Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling,” Diabetes, vol. 62, no. 7, pp. 2318–2328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Cao, C. Vecoli, D. Neglia et al., “Cobalt-protoporphyrin improves heart function by blunting oxidative stress and restoring NO synthase equilibrium in an animal model of experimental diabetes,” Frontiers in Physiology, vol. 3, p. 160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Cremon, V. Stanghellini, M. R. Barbaro et al., “Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 45, no. 7, pp. 909–922, 2017. View at Publisher · View at Google Scholar · View at Scopus
  61. E. Tartaglia, M. Armentano, B. Giugliano et al., “Effectiveness of the association N-palmitoylethanolamine and transpolydatin in the treatment of primary dysmenorrhea,” Journal of Pediatric and Adolescent Gynecology, vol. 28, no. 6, pp. 447–450, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Wang, J. Ye, J. Li et al., “Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9),” Cardiovascular Diabetology, vol. 15, no. 1, p. 19, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Zhang, S. Wang, Z. Cheng et al., “Polydatin ameliorates diabetic cardiomyopathy via Sirt3 activation,” Biochemical and Biophysical Research Communications, vol. 493, no. 3, pp. 1280–1287, 2017. View at Publisher · View at Google Scholar
  64. K. K. Wu and Y. Huan, “Streptozotocin-induced diabetic models in mice and rats,” Current Protocols in Pharmacology, 2008, Chapter 5, pp. Unit 5.47. View at Publisher · View at Google Scholar · View at Scopus
  65. B. A. Kerr, X. Z. West, Y. W. Kim et al., “Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium,” Nature Communications, vol. 7, article 10960, 2016. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Yu, Y. Zhang, W. Guan et al., “Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation,” Molecular Cancer Research, vol. 12, no. 6, pp. 830–842, 2014. View at Publisher · View at Google Scholar · View at Scopus